Cantor Fitzgerald Reiterates Overweight on Braze, Maintains $38 Price Target
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsReiterationPrice Target
Cantor Fitzgerald analyst Matthew Vanvliet reiterates Braze (NASDAQ:BRZE) with a Overweight and maintains $38 price target.
Cantor Fitzgerald analyst Matthew Vanvliet reiterates Braze (NASDAQ:BRZE) with a Overweight and maintains $38 price target.